Biosimilar Products in Rheumatoid Arthritis: Role of the Pharmacist
This Continuing Education activity is supported by an educational grant from Sandoz, Inc.
This activity is supported by an educational grant from Sandoz, Inc.
Geoffrey C. Wall, PharmD, FCCP, BCPS, CGPProfessor of Clinical SciencesDrake University College of Pharmacy and Health SciencesDes Moines, IAThomas J. Cook, PhD, RPhDirector of Graduate EducationGlobalscope IncNew York, NYFreelance Medical Writer
After completing this continuing education program, the participant will be able to:
- Examine the changing landscape of rheumatoid arthritis (RA) biosimilar products.
- Explain the potential impact of RA biosimilar products on their practice.
- Identify strategies to address barriers to the use of RA biosimilar products.
Target audience: Pharmacists
Type of activity: Knowledge or Application (select one)
Release date: March 15, 2017
Expiration date: March 15, 2018
Estimated time to complete activity: 2.0 hours
Pharmacy Times Continuing Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-17-013-H01-P. The activity is available for CE credit through March 15, 2018.